{"id":7341,"date":"2025-11-18T11:45:03","date_gmt":"2025-11-18T10:45:03","guid":{"rendered":"https:\/\/www.thescon.de\/?p=7341"},"modified":"2025-11-18T11:46:01","modified_gmt":"2025-11-18T10:46:01","slug":"fdas-csa-final-guidance-clarity-practicality-digitalization","status":"publish","type":"post","link":"https:\/\/www.thescon.de\/en\/fdas-csa-final-guidance-clarity-practicality-digitalization\/","title":{"rendered":"FDA\u2019s CSA Final Guidance: Clarity, Practicality, Digitalization"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Why CSA Is the Evolution of CSV<\/h3>

CSA Final Guidance 2025: Key Updates<\/strong><\/p>

CSA Final Guidance by the FDA: More Clarity, More Practicality, More Digitalization<\/strong><\/p>

With the publication of the CSA Final Guidance in 2025, the FDA addresses long-standing challenges in the validation of computerized systems. The new guideline is based on a risk-based, agile, and digital approach \u2013 a significant step toward modern quality assurance.<\/p>

Why CSA?<\/strong><\/p>

Classical Computer System Validation (CSV) is often characterized by extensive documentation, long project timelines, and a focus on paperwork rather than actual risks. Despite intensive validation activities, issues continue to appear after go-live. The FDA recognized the need for action and developed a CSA guideline that supplements and partially replaces Section 6 of the previous \u201cSoftware Validation Guidance\u201d from 2002. Numerous criticisms of the 2022 CSA Draft were addressed and incorporated into the 2025 Final Guidance.<\/p>

What is new?<\/strong><\/p>

The CSA Final Guidance<\/strong> introduces key innovations:<\/p>

  • Risk orientation:<\/strong> Validation effort is aligned with actual process risk and intended use.<\/li>
  • Flexible test methods:<\/strong> Exploratory and automated testing are explicitly encouraged.<\/li>
  • Digital evidence: <\/strong>Logs, audit trails, and electronic signatures replace paper-heavy documentation.<\/li>
  • Supplier assessment: <\/strong>Clear criteria for vendor assurance, including certificates and audit readiness.<\/li>
  • Cloud & SaaS:<\/strong> Clear statements on validating modern software architectures and CI\/CD environments.<\/li>
  • GAMP 5 compatibility:<\/strong> CSA is understood as an evolution and harmonization with existing standards.<\/li><\/ul>

    \u00a0<\/p>

    What does this mean for regulated companies?<\/strong><\/p>

    The new CSA Guidance offers more freedom\u2014but also more responsibility. Companies must develop their own risk-based classifications and documentation strategies. The FDA remains intentionally high-level to allow flexibility. At the same time, CSA is described as fully compliant with CFR Part 11 and Part 820 \u2013 a clear signal to auditors and inspectors.<\/p>

    CSA is not a revolution, but an evolution of CSV. Companies should:<\/p>

    • Classify their software landscape based on functionality<\/li>
    • Rethink existing testing and documentation strategies<\/li>
    • Use digital evidence in a targeted and auditable way<\/li>
    • Adjust supplier relationships and contractual frameworks<\/li><\/ul>

      \u00a0<\/p>

      Register now: Understand and implement CSA correctly<\/strong><\/p>

      You would like to know how to implement the new requirements efficiently and in a compliant manner? Then register for our webinar. Our expert Dr. Alina M\u00fcller-Rudorf will not only present the core principles of CSA but also specifically highlight the changes and clarifications compared to the 2022 draft.<\/p>

      Webinar details:<\/span><\/p>

      • Topics<\/strong>:
        • Core elements of the CSA Final Guidance<\/li>
        • Opportunities and challenges arising from CSA<\/li>
        • Recommendations for your CSA approach<\/li><\/ul><\/li><\/ul>

          \u00a0<\/p>

          • Date<\/strong>: 28 November 2025<\/li>
          • Time<\/strong>: 10:00 a.m.<\/li>
          • Duration<\/strong>: 30 minutes<\/li><\/ul>

            \u00a0<\/p>

            Thescon has many years of experience and deep expertise in the regulated industry and is your independent industry expert for the validation of computerized systems. The new CSA Final Guidance by the FDA creates numerous opportunities but also challenges for companies. In our free webinars, you will receive a comprehensive overview of the most important changes, practical implementation approaches, and concrete recommendations for your CSA strategy.<\/p>

            Register via our contact form to receive your personal invitation links. After registration, we will send you the access details for the free webinars.<\/p>

            We look forward to your participation!<\/p>

            Note<\/strong>: Our web seminars are a service for Thescon customers and prospects. Service providers and consultants are excluded from participation.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

            What the New FDA Guidance Means for Companies<\/p>\n

            The new FDA CSA Final Guidance introduces stronger risk orientation, flexible testing methods, and digital evidence. Learn how companies can benefit from this modern and practical approach\u2014and what steps to take next.<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,16,13],"tags":[],"class_list":["post-7341","post","type-post","status-publish","format-standard","hentry","category-events","category-news","category-web-seminars"],"_links":{"self":[{"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/posts\/7341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/comments?post=7341"}],"version-history":[{"count":8,"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/posts\/7341\/revisions"}],"predecessor-version":[{"id":7354,"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/posts\/7341\/revisions\/7354"}],"wp:attachment":[{"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/media?parent=7341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/categories?post=7341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thescon.de\/en\/wp-json\/wp\/v2\/tags?post=7341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}